Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Ascendis Pharma A/S
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
311.13 |
695.41 |
1,272.23 |
1,950.95 |
2,677.13 |
3,369.75 |
| Przychód Δ r/r |
0.00% |
123.51% |
82.95% |
53.35% |
37.22% |
25.87% |
| Przychód (min) |
268.29 |
588.23 |
964.29 |
1,549.00 |
2,125.57 |
2,675.48 |
| Przychód (max) |
379.42 |
983.16 |
1,763.12 |
2,659.42 |
3,649.30 |
4,593.44 |
| EBITDA (średnia) |
-298.54 |
-667.25 |
-1,220.71 |
-1,871.95 |
-2,568.73 |
-3,233.31 |
| EBIT (średnia) |
-301.57 |
-674.03 |
-1,233.11 |
-1,890.96 |
-2,594.82 |
-3,266.14 |
| EBIT % |
-96.93% |
-96.93% |
-96.93% |
-96.93% |
-96.93% |
-96.93% |
| Zysk netto (średni) |
-386.08 |
-270.14 |
164.24 |
594.22 |
944.54 |
1,287.11 |
| Zysk netto % |
-124.09% |
-38.85% |
12.91% |
30.46% |
35.28% |
38.20% |
| EPS (średnia) |
-6.84 |
-4.67 |
2.05 |
9.70 |
16.32 |
22.23 |
| Liczba analityków (Przychody) |
10 |
11 |
15 |
11 |
4 |
5 |
| Liczba analityków (EPS) |
10 |
10 |
12 |
8 |
7 |
6 |
| symbol |
ASND |
ASND |
ASND |
ASND |
ASND |
ASND |